Sentrex Bio

Sentrex Bio is a pre-clinical stage biotechnology company focused on developing next-generation ion transport modulators for the treatment of cardiovascular and renal diseases. The company leverages its proprietary platform to design highly selective small molecules that target specific solute carrier (SLC) transporters, aiming to overcome the limitations of traditional diuretics such as electrolyte imbalances and resistance. Their lead programs focus on optimizing the balance of sodium and potassium excretion to provide safer and more effective options for patients with hypertension and congestive heart failure. Sentrex Bio is positioned to address significant unmet needs in the management of fluid overload and blood pressure regulation.